Researchers
Human Whole Blood
Obtain human serum samples for event-based and longitudinal collection.
We can help you:
- Meet any study timeline
- Obtain samples from hard-to-reach patient populations
- Follow up long-term with study participants
Whole Blood Samples
Our whole blood samples are suitable for numerous downstream applications. With every human whole blood sample, you’ll receive detailed patient data that’s validated through medical record review, so you can confidently develop your next therapeutic or diagnostic solution.
![img-blood rack img-blood rack](https://sanguinebio.com/wp-content/uploads/2022/07/img-blood-rack.jpg)
- Standardized sample collection and storage protocols
- Same-day or next day delivery including disease-associated event-based samples
- High quality and cell viability
Whole blood can be further processed if you need to isolate specific cell types, including plasma isolation from whole blood.
Why Sanguine
Compliance & Quality Assured
Sanguine utilizes two internationally-recognized IRBs (Advarra and WCG IRB) for review and approval of all study protocols, specific study documentation, and study participant facing information. Both Advarra and WCG IRB are organized and operates in compliance with: FDA, OHRP, and International Conference on Harmonization (ICH).
Sanguine operates under an electronic informed consent process which executes 21 CFR part 11 compliant e-signatures, and Sanguine systems interacting with study participant information are HIPAA-compliant.
![Group 30@2x Group 30@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-30@2x.png)
Access to over 70,000 patient members nationwide
![Group 23@2x Group 23@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-23@2x.png)
![Group 23@2x Group 23@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-23@2x.png)
![Group 23@2x Group 23@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-23@2x.png)
Longitudinal and event-based biospecimen and data collection
![Group 29@2x Group 29@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-29@2x.png)
![Group 29@2x Group 29@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-29@2x.png)
![Group 29@2x Group 29@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-29@2x.png)
99% Patient recall rate
![Group 25@2x Group 25@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-25@2x.png)
![Group 25@2x Group 25@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-25@2x.png)
![Group 25@2x Group 25@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-25@2x.png)
Over 1000 studies completed with 93% study retention rate
![Group 28@2x Group 28@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-28@2x.png)
![Group 28@2x Group 28@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-28@2x.png)
![Group 28@2x Group 28@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-28@2x.png)
9.6 Patient satisfaction score
![Group 26@2x Group 26@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-26@2x.png)
![Group 26@2x Group 26@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-26@2x.png)
![Group 26@2x Group 26@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-26@2x.png)
Biospecimens for a variety of disease research areas
![Group 27@2x Group 27@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-27@2x.png)
![Group 27@2x Group 27@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-27@2x.png)
![Group 27@2x Group 27@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-27@2x.png)
Same-day sample collection and delivery
![Group 30@2x Group 30@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-30@2x.png)
![Group 30@2x Group 30@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-30@2x.png)
![Group 30@2x Group 30@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-30@2x.png)
Access to over 70,000 patient members nationwide
![Group 23@2x Group 23@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-23@2x.png)
![Group 23@2x Group 23@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-23@2x.png)
![Group 23@2x Group 23@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-23@2x.png)
Longitudinal and event-based biospecimen and data collection
![Group 29@2x Group 29@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-29@2x.png)
![Group 29@2x Group 29@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-29@2x.png)
![Group 29@2x Group 29@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-29@2x.png)
99% Patient recall rate
![Group 25@2x Group 25@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-25@2x.png)
![Group 25@2x Group 25@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-25@2x.png)
![Group 25@2x Group 25@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-25@2x.png)
Over 1000 studies completed with 93% study retention rate
![Group 28@2x Group 28@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-28@2x.png)
![Group 28@2x Group 28@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-28@2x.png)
![Group 28@2x Group 28@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-28@2x.png)
9.6 Patient satisfaction score
![Group 26@2x Group 26@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-26@2x.png)
![Group 26@2x Group 26@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-26@2x.png)
![Group 26@2x Group 26@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-26@2x.png)
Biospecimens for a variety of disease research areas
![Group 27@2x Group 27@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-27@2x.png)
![Group 27@2x Group 27@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-27@2x.png)
![Group 27@2x Group 27@2x](https://sanguinebio.com/wp-content/uploads/2022/07/Group-27@2x.png)